Home/Filings/3/0001209191-15-041354
3//SEC Filing

MERRILL CORP /NEW/ - FA 3

Accession 0001209191-15-041354

CIK 0001047469other

Filed

May 10, 8:00 PM ET

Accepted

May 11, 9:12 PM ET

Size

10.0 KB

Accession

0001209191-15-041354

Insider Transaction Report

Form 3
Period: 2015-05-06
Holdings
  • Series C Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (382,323 underlying)
  • Series B Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (1,552,795 underlying)
  • Series D Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (852,423 underlying)
Holdings
  • Series C Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (382,323 underlying)
  • Series B Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (1,552,795 underlying)
  • Series D Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (852,423 underlying)
Holdings
  • Series C Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (382,323 underlying)
  • Series D Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (852,423 underlying)
  • Series B Convertible Preferred Stock

    (indirect: see footnote)
    Common Stock (1,552,795 underlying)
Footnotes (2)
  • [F1]All series of Convertible Preferred Stock will automatically convert into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and have no expiration date.
  • [F2]The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC and disclaim beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of their proportionate pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.

Issuer

MERRILL CORP /NEW/ - FA

CIK 0001047469

Entity typeother
IncorporatedMN

Related Parties

1
  • filerCIK 0001047469

Filing Metadata

Form type
3
Filed
May 10, 8:00 PM ET
Accepted
May 11, 9:12 PM ET
Size
10.0 KB